{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T13:57:29Z","timestamp":1773583049449,"version":"3.50.1"},"reference-count":235,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT 107064"],"award-info":[{"award-number":["WT 107064"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC Metabolic Disease Unit"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbalip.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:18:56Z","timestamp":1549826336000},"page":"715-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Gene-gene and gene-environment interactions in lipodystrophy: Lessons learned from natural PPAR\u03b3 mutants"],"prefix":"10.1016","volume":"1864","author":[{"given":"M.F.","family":"Broekema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Monajemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kalkhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2019.02.002_bb0005","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2016-2466","article-title":"The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline","author":"Brown","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-1159","article-title":"Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3700","article-title":"Prospective functional classification of all possible missense variants in PPARG","author":"Majithia","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0025","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24 , is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1750-1172-8-106","article-title":"Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome","volume":"8","author":"Donadille","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ng.2670","article-title":"An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy","volume":"45","author":"Weedon","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216134","article-title":"Barraquer-Simons syndrome: a unique patient\u2019s perspective on diagnosis, disease progression and recontouring treatment","volume":"2016","author":"Heidemann","year":"2016","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12981-015-0061-z","article-title":"Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders","volume":"12","author":"Verolet","year":"2015","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0050","article-title":"\u201cWe\u2019re stuck with what we\u2019ve got\u201d: The impact of lipodystrophy on body image","volume":"0","author":"Adams","year":"2018","journal-title":"J. Clin. Nurs."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with berardinelli-seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0070","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2014new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPAR gamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0090","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/emmm.200900037","article-title":"Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC","volume":"1","author":"Rubio-Cabezas","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mus.24157","article-title":"Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin","volume":"49","author":"Carboni","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0105","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","article-title":"Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1073\/pnas.1408523111","article-title":"Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease","volume":"111","author":"Payne","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86870","article-title":"Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy","volume":"1","author":"Garg","year":"2016","journal-title":"JCI Insight."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23813","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","volume":"6","author":"Rocha","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0130","article-title":"Multiple Symmetric Lipomatosis (Madelung Disease) in a Large Canadian Family With the Mitochondrial MTTK c.8344A>G Variant","volume":"6","author":"Perera","year":"2018","journal-title":"J. Investig. Med. High Impact Case Reports."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2017-02662","article-title":"PLIN1 haploinsufficiency is not associated with lipodystrophy","author":"Laver","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejmg.2014.06.006","article-title":"Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome","volume":"57","author":"Dyment","year":"2014","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ajmg.a.37115","article-title":"U. of W.C. for M. Genomics, Whole Exome Sequencing Identifies De Novo Heterozygous CAV1 Mutations Associated with a Novel Neonatal Onset Lipodystrophy Syndrome","author":"Garg","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01363","article-title":"A Single Complex Agpat2 Allele In A Patient With Partial Lipodystrophy","volume":"9","author":"Broekema","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","article-title":"Genetic disorders of adipose tissue development, differentiation, and death","volume":"7","author":"Agarwal","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1210\/me.2009-0073","article-title":"Decreased PPAR\u03b3 Expression Compromises Perigonadal-Specific Fat Deposition and Insulin Sensitivity","volume":"23","author":"Tsai","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0180","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1073\/pnas.1410428111","article-title":"Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes","volume":"111","author":"Majithia","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng926","article-title":"Digenic inheritance of severe insulin resistance in a human pedigree","volume":"31","author":"Savage","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0190","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbadis.2010.01.012","article-title":"A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia","volume":"1802","author":"Capaccio","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0195","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1128\/MCB.02266-05","article-title":"Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery","volume":"26","author":"Nielsen","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0200","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1101\/gad.501108","article-title":"Genome-wide profiling of PPAR\u03b3:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis","volume":"22","author":"Nielsen","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.celrep.2014.04.042","article-title":"Transcription factor cooperativity in early adipogenic hotspots and super-enhancers","volume":"7","author":"Siersb\u00e6k","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0210","doi-asserted-by":"crossref","first-page":"1459 LP","DOI":"10.1038\/emboj.2011.65","article-title":"Extensive chromatin remodelling and establishment of transcription factor \u2018hotspots\u2019 during early adipogenesis","volume":"30","author":"Siersb\u00e6k","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0215","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1128\/MCB.00526-12","article-title":"Genome-Wide Profiling of Peroxisome Proliferator-Activated Receptor \u03b3 in Primary Epididymal, Inguinal, and Brown Adipocytes Reveals Depot-Selective Binding Correlated with Gene Expression","volume":"32","author":"Siersbaek","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0220","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/MCB.01344-13","article-title":"Peroxisome Proliferator-Activated Receptor \u03b3 and C\/EBP\u03b1 Synergistically Activate Key Metabolic Adipocyte Genes by Assisted Loading","volume":"34","author":"Madsen","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0225","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.molcel.2017.04.010","article-title":"Dynamic Rewiring of Promoter-Anchored Chromatin Loops during Adipocyte Differentiation","volume":"66","author":"Siersb\u00e6k","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0230","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1101\/gad.1709008","article-title":"PPAR\u03b3 and C\/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale","volume":"22","author":"Lefterova","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0235","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/MCB.01651-09","article-title":"Cell-Specific Determinants of Peroxisome Proliferator-Activated Receptor \u03b3 Function in Adipocytes and Macrophages Cell-Specific Determinants of Peroxisome Proliferator-Activated Receptor \u2425 Function in Adipocytes and Macrophages \u1c14 \u00a7","volume":"30","author":"Lefterova","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0240","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisomal \u03b2-oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1101\/gad.948702","article-title":"C\/EBP\u03b1 induces adipogenesis through PPAR\u03b3: a unified pathway","volume":"16","author":"Rosen","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0250","doi-asserted-by":"crossref","first-page":"4543 LP","DOI":"10.1073\/pnas.0400356101","article-title":"Peroxisome proliferator-activated receptor \u03b3 is required in mature white and brown adipocytes for their survival in the mouse","volume":"101","author":"Imai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0255","first-page":"281","article-title":"Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping","volume":"4","author":"Greene","year":"1995","journal-title":"Gene Expr."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0260","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The Organization, Promoter Analysis, and Expression of the Human PPAR\u03b3 Gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0265","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/endo.142.10.8458","article-title":"Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding","volume":"142","author":"Escher","year":"2001","journal-title":"Endocrinology."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0270","doi-asserted-by":"crossref","first-page":"41925","DOI":"10.1074\/jbc.M206950200","article-title":"Genetic Analysis of Adipogenesis through Peroxisome Proliferator-activated Receptor \u03b3 Isoforms","volume":"277","author":"Mueller","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0275","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.celrep.2018.10.035","article-title":"PPAR\u03b3\u22065, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPAR\u03b3 Function and Adipocyte Differentiation","volume":"25","author":"Aprile","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0280","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1101\/gad.1907110","article-title":"Propagation of adipogenic signals through an epigenomic transition state","volume":"24","author":"Steger","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0285","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cell.2010.09.006","article-title":"Comparative epigenomic analysis of murine and human adipogenesis","volume":"143","author":"Mikkelsen","year":"2010","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0290","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm3198","article-title":"Forming functional fat: a growing understanding of adipocyte differentiation","volume":"12","author":"Cristancho","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0295","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.febslet.2011.05.007","article-title":"Epigenetic codes of PPAR?? in metabolic disease","volume":"585","author":"Sugii","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7007-7-38","article-title":"Expression of the peroxisome proliferator activated receptor \u03b3 gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes","volume":"7","author":"Fujiki","year":"2009","journal-title":"BMC Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0305","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/MCB.01856-08","article-title":"The Peroxisome Proliferator-Activated Receptor \u03b3\/Retinoid X Receptor \u03b1 Heterodimer Targets the Histone Modification Enzyme PR-Set7\/Setd8 Gene and Regulates Adipogenesis through a Positive Feedback Loop","volume":"29","author":"Wakabayashi","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0310","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1101\/gad.5.9.1538","article-title":"Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells","volume":"5","author":"Cao","year":"1991","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/bbrc.1997.7627","article-title":"CAAT\/Enhancer Binding Proteins Directly Modulate Transcription from the Peroxisome Proliferator- Activated Receptor \u03b32 Promoter","volume":"240","author":"Clarke","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0320","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.88.6.2593","article-title":"CCAAT\/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes","volume":"88","author":"Christy","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0325","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(00)80306-8","article-title":"Cross-Regulation of C\/EBP\u03b1 and PPAR\u03b3 Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity","volume":"3","author":"Wu","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0330","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M003593200","article-title":"Modulation of the Murine Peroxisome Proliferator-Activated Receptor\u03b32 Promoter Activity by CCAAT\/Enhancer Binding Proteins","author":"Elberg","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0335","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1074\/jbc.M510682200","article-title":"Activation of CCAAT\/Enhancer-binding Protein (C\/EBP) \u03b1 Expression by C\/EBP\u03b2 during Adipogenesis Requires a Peroxisome Proliferator-activated Receptor-\u03b3-associated Repression of HDAC1 at the C\/ebp\u03b1 Gene Promoter","volume":"281","author":"Zuo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2004.11.005","article-title":"Kr\u00fcppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation","volume":"1","author":"Oishi","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0345","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cdd.2010.100","article-title":"Kr\u00fcppel-like factor KLF9 regulates PPAR\u03b3 transactivation at the middle stage of adipogenesis","volume":"18","author":"Pei","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0350","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1074\/jbc.M210859200","article-title":"The Kr\u00fcppel-like Factor KLF2 Inhibits Peroxisome Proliferator-activated Receptor-\u03b3 Expression and Adipogenesis","volume":"278","author":"Sen Banerjee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0355","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1128\/MCB.19.8.5495","article-title":"Regulation of Peroxisome Proliferator-Activated Receptor \u03b3 Expression by Adipocyte Differentiation and Determination Factor 1\/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism","volume":"19","author":"Fajas","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0360","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","article-title":"ADD1\/SREBP1 activates PPAR\u03b3 through the production of endogenous ligand","volume":"95","author":"Kim","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0365","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1126\/science.290.5489.134","article-title":"Function of GATA Transcription Factors in Preadipocyte-Adipocyte Transition","volume":"290","author":"Tong","year":"2000","journal-title":"Science (80-. )"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0370","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1128\/MCB.25.2.706-715.2005","article-title":"Interaction between GATA and the C\/EBP Family of Transcription Factors Is Critical in GATA-Mediated Suppression of Adipocyte Differentiation","volume":"25","author":"Tong","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0375","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004699","article-title":"MicroRNA Expression in Human Omental and Subcutaneous Adipose Tissue","volume":"4","author":"Kl\u00f6ting","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0385","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2010.01.012","article-title":"miR-27a is a negative regulator of adipocyte differentiation via suppressing PPAR\u03b3 expression","volume":"392","author":"Kim","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2009.09.098","article-title":"microRNA miR-27b impairs human adipocyte differentiation and targets PPAR\u03b3","volume":"390","author":"Karbiener","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0395","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/MCB.00894-10","article-title":"miR-130 Suppresses Adipogenesis by Inhibiting Peroxisome Proliferator-Activated Receptor \u03b3 Expression","volume":"31","author":"Lee","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0400","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.febslet.2014.07.035","article-title":"MicroRNA\u2010302a inhibits adipogenesis by suppressing peroxisome proliferator\u2010activated receptor \u03b3 expression","volume":"588","author":"Byung-Chul","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0405","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1038\/srep03819","article-title":"MicroRNA-143 Regulates Adipogenesis by Modulating the MAP2K5\u2013ERK5 Signaling","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0410","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1093\/nar\/gks025","article-title":"Dataset integration identifies transcriptional regulation of microRNA genes by PPAR\u03b3 in differentiating mouse 3T3-L1 adipocytes","volume":"40","author":"John","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0415","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JME-13-0173","article-title":"Understanding nuclear receptor form and function using structural biology","volume":"51","author":"Rastinejad","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0420","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/oby.2008.473","article-title":"Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator","volume":"17","author":"van Beekum","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0425","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR-gamma-RXR- alfa nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0430","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1093\/nar\/22.25.5628","article-title":"Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR\u03b3 and RXRa","volume":"22","author":"Tontonoz","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0435","series-title":"Nucleic Acids , Protein Synthesis , And Molecular Genetics\u202f: Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor ( PPAR )\/ Retinoid X Receptor Heterodimer Binding to DNA\u202f: A Functional Analysis Of The Malic Enzyme Gen","first-page":"20108","volume":"272","author":"Ijpenberg","year":"1997"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0440","doi-asserted-by":"crossref","first-page":"25252","DOI":"10.1074\/jbc.272.40.25252","article-title":"DNA Binding Properties of Peroxisome Proliferator-activated Receptor Subtypes on Various Natural Peroxisome Proliferator Response Elements: IMPORTANCE OF THE 5\u2032-FLANKING REGION","volume":"272","author":"Juge-Aubry","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0445","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors \u03b1 and \u03b3","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0450","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-\u039412,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPAR\u03b3","volume":"83","author":"Forman","year":"1995","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0455","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor \u03b3 and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPAR\u03b3","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0465","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI200318012","article-title":"Biosynthesis of 15-deoxy-\u039412,14-PGJ2 and the ligation of PPAR\u03b3","volume":"112","author":"Bell-Parikh","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0470","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0475","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/187153006776056620","article-title":"Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases","volume":"6","author":"Balint","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0480","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor \u03b3 (PPAR\u03b3)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0485","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2337\/diacare.22.2.288","article-title":"Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes","volume":"22","author":"Kelly","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0490","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8227(01)00319-9","article-title":"Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation\u2014double-blind placebo-controlled trial","volume":"54","author":"Nakamura","year":"2001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0495","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/diacare.23.8.1067","article-title":"Efficacy of troglitazone on body fat distribution in type 2 diabetes","volume":"23","author":"Akazawa","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0500","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0505","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0510","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature09291","article-title":"Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5","volume":"466","author":"Choi","year":"2010","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0515","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature10383","article-title":"Antidiabetic actions of a non-agonist PPAR\u03b3 ligand blocking Cdk5-mediated phosphorylation","volume":"477","author":"Choi","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0520","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature13887","article-title":"An ERK\/Cdk5 axis controls the diabetogenic actions of PPAR\u03b3","volume":"517","author":"Banks","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0525","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cell.2012.06.027","article-title":"Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Ppar\u03b3","volume":"150","author":"Qiang","year":"2012","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0530","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.molmet.2015.02.007","article-title":"Adipocyte SIRT1 knockout promotes PPAR\u03b3 activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity","volume":"4","author":"Mayoral","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0535","doi-asserted-by":"crossref","DOI":"10.1172\/JCI98709","article-title":"PPAR\u03b3 deacetylation dissociates thiazolidinedione\u2019s metabolic benefits from its adverse effects","volume":"128","author":"Kraakman","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0540","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2443.2004.00786.x","article-title":"The transactivating function of peroxisome proliferator\u2010activated receptor \u03b3 is negatively regulated by SUMO conjugation in the amino\u2010terminal domain","volume":"9","author":"Daisuke","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0545","first-page":"921","article-title":"Control of Peroxisome Proliferator\u2010Activated Receptor \u03b32 Stability and Activity by SUMOylation","volume":"12","author":"Elizabeth","year":"2012","journal-title":"Obes. Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0550","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11010-005-9052-z","article-title":"Aspects of the regulatory mechanisms of PPAR functions: Analysis of a bidirectional response element and regulation by sumoylation","volume":"286","author":"Shimizu","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0555","doi-asserted-by":"crossref","first-page":"29551","DOI":"10.1074\/jbc.M403866200","article-title":"Transcriptional Activity of Peroxisome Proliferator-activated Receptor \u03b3 Is Modulated by SUMO-1 Modification","volume":"279","author":"Ohshima","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0560","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2011.12.086","article-title":"O-GlcNAc modification of PPAR\u03b3 reduces its transcriptional activity","volume":"417","author":"Ji","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0565","doi-asserted-by":"crossref","first-page":"18527","DOI":"10.1074\/jbc.M001297200","article-title":"Degradation of the Peroxisome Proliferator-activated Receptor \u03b3 Is Linked to Ligand-dependent Activation","volume":"275","author":"Hauser","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0570","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1074\/jbc.M007894200","article-title":"Interferon-\u03b3-induced Regulation of Peroxisome Proliferator-activated Receptor \u03b3 and STATs in Adipocytes","volume":"276","author":"Waite","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0575","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1074\/jbc.M108473200","article-title":"Interferon-\u03b3-mediated Activation and Ubiquitin-Proteasome-dependent Degradation of PPAR\u03b3 in Adipocytes","volume":"277","author":"Floyd","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0580","doi-asserted-by":"crossref","first-page":"317","DOI":"10.14310\/horm.2002.1585","article-title":"Familial partial lipodystrophy type 3: a new mutation on the PPARG gene","volume":"14","author":"Lau","year":"2015","journal-title":"Horm."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0585","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/ATVBAHA.112.300962","article-title":"Peroxisome proliferator-activated receptor-\u03b3 mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system","volume":"33","author":"Auclair","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0590","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2005-2624","article-title":"Peroxisome Proliferator-Activated Receptor-\u03b3 C190S Mutation Causes Partial Lipodystrophy","volume":"92","author":"L\u00fcdtke","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0595","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2006-1807","article-title":"Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma","volume":"92","author":"Monajemi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0600","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2337\/db17-1236","article-title":"A Pharmacogenetic Approach to the Treatment of Patients with PPARG Mutations","volume":"67","author":"Agostini","year":"2018","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0605","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.12837","article-title":"Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3","volume":"84","author":"Miehle","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0610","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diabet.2012.02.012","article-title":"Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: a possible role for peroxisome proliferator-activated receptor \u03b3","volume":"38","author":"Castell","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0615","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-\u03b3 deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0620","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a Transactivation-Deficient Mutant, in Familial Partial Lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0625","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2007.050567","article-title":"New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand","volume":"44","author":"L\u00fcdtke","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0630","first-page":"408","article-title":"A Novel Heterozygous Mutation in Peroxisome Proliferator-Activated Receptor-\u03b3 Gene in a Patient with Familial Partial Lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0635","series-title":"Leptin therapy for partial lipodystrophy linked to a PPAR-\u03b3 mutation","first-page":"547","volume":"68","author":"Guettier","year":"2008"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0640","article-title":"Natural helix 9 mutants of PPAR\u03b3 differently affect its transcriptional activity","author":"Broekema","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0645","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14341\/DM2015399-105","article-title":"Development of metabolic syndrome at a young age as a manifestation of familial partial lipodystrophy type 3 (PPARG mutation): the first description of its clinical case in Russia","volume":"18","author":"Sorkina","year":"2015","journal-title":"Diabetes Mellit."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0650","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1210\/jc.2004-0280","article-title":"A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy","volume":"89","author":"Al-Shali","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0655","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-0004.2006.00674.x","article-title":"A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367)","volume":"70","author":"Hegele","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0660","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPAR\u03b3 mutations cause lipodystrophic insulin resistance","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0665","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-011-2142-4","article-title":"Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPAR\u03b3 mutation (Y151C)","volume":"54","author":"Visser","year":"2011","journal-title":"Diabetologia."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0670","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1210\/jc.2016-1005","article-title":"Natural history of congenital generalized lipodystrophy: A nationwide study from Turkey","volume":"101","author":"Akinci","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0675","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1194\/jlr.P025437","article-title":"Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPAR\u03b3 deficiency","volume":"53","author":"Campeau","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0680","doi-asserted-by":"crossref","first-page":"R1286","DOI":"10.1152\/ajpregu.00653.2001","article-title":"Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes","volume":"282","author":"Tchkonia","year":"2002","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0685","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tem.2009.04.005","article-title":"Functional implications of genetic variation in human PPAR\u03b3","volume":"20","author":"Jeninga","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0690","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","article-title":"Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism","volume":"48","author":"Hegele","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0695","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/me.2006-0485","article-title":"Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy","volume":"21","author":"Jeninga","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0700","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2013.10.058","article-title":"Leveraging Cross-Species Transcription Factor Binding Site Patterns: From Diabetes Risk Loci to Disease Mechanisms","volume":"156","author":"Claussnitzer","year":"2014","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0705","doi-asserted-by":"crossref","first-page":"1864 LP","DOI":"10.2337\/diabetes.52.7.1864","article-title":"A Functional Variant in the Peroxisome Proliferator-Activated Receptor \u03b32 Promoter Is Associated With Predictors of Obesity and Type 2 Diabetes in Pima Indians","volume":"52","author":"Muller","year":"2003","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0710","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/01.ATV.0000051382.28752.FE","article-title":"A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population","volume":"23","author":"Meirhaeghe","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0715","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ymgme.2005.02.004","article-title":"Study of a new PPAR\u03b32 promoter polymorphism and haplotype analysis in a French population","volume":"85","author":"Meirhaeghe","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0720","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1038\/nutd.2015.19","article-title":"Regional distribution of body fat in relation to DNA methylation within the LPL, ADIPOQ and PPAR\u03b3 promoters in subcutaneous adipose tissue","volume":"5","author":"Drogan","year":"2015","journal-title":"Nutr. &Amp; Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0725","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1172\/JCI118703","article-title":"Regulation of PPAR gamma gene expression by nutrition and obesity in rodents","volume":"97","author":"Vidal-Puig","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0730","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072124","article-title":"PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity","volume":"19","author":"Corrales","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0740","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-\u03b3","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0745","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1111\/j.1464-5491.2012.03742.x","article-title":"A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation","volume":"29","author":"Madhra","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0750","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2007-2521","article-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy","volume":"93","author":"Vantyghem","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0755","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/bst0290227","article-title":"Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor \u03b3 resistance","volume":"29","author":"Chatterjee","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0760","first-page":"E522","article-title":"Downregulated IRS-1 and PPAR\u03b3 in obese women with gestational diabetes: relationship to FFA during pregnancy","volume":"282","author":"Catalano","year":"2002","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0765","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2119\/molmed.2015.00262","article-title":"Peroxisome Proliferator-Activated Receptor \u03b3 2 Modulates Late-Pregnancy Homeostatic Metabolic Adaptations","volume":"22","author":"Vivas","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0770","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR\u03b3 Is Required for Placental, Cardiac, and Adipose Tissue Development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0775","first-page":"1","article-title":"A Brief Overview of Preeclampsia","volume":"6","author":"Al-Jameil","year":"2014","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0780","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1113\/JP271691","article-title":"\u2018Adipaging\u2019: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue","volume":"594","author":"P\u00e9rez","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0785","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","article-title":"Mechanisms and metabolic implications of regional differences among fat depots","volume":"17","author":"Tchkonia","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0790","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ajcn\/70.3.405","article-title":"Aging, body composition, and lifestyle: the Fels Longitudinal Study","volume":"70","author":"Guo","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0795","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature06902","article-title":"Dynamics of fat cell turnover in humans","volume":"453","author":"Spalding","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0800","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1001\/jama.2010.843","article-title":"Association between adiposity in midlife and older age and risk of diabetes in older adults","volume":"303","author":"ML","year":"2010","journal-title":"JAMA."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0805","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2014.12.122","article-title":"Telomere length differences between subcutaneous and visceral adipose tissue in humans","volume":"457","author":"Lakowa","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0810","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.metabol.2012.08.007","article-title":"Peripheral Fat Loss and Decline in Adipogenesis in Older Humans","volume":"62","author":"Caso","year":"2013","journal-title":"Metabolism."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0815","doi-asserted-by":"crossref","first-page":"R1772","DOI":"10.1152\/ajpregu.2001.280.6.R1772","article-title":"Altered expression of C\/EBP family members results in decreased adipogenesis with aging","volume":"280","author":"Karagiannides","year":"2001","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0820","doi-asserted-by":"crossref","first-page":"B183","DOI":"10.1093\/gerona\/54.5.B183","article-title":"Age-related adipose tissue mRNA expression of ADD1\/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys","volume":"54","author":"Hotta","year":"1999","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0825","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000090951","article-title":"Effect of Aging on the Expression of Peroxisome Proliferator-Activated Receptor \u03b3 and the Possible Relation to Insulin Resistance","volume":"52","author":"Ye","year":"2006","journal-title":"Gerontology."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0830","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cmet.2012.07.017","article-title":"Role of MicroRNA Processing in Adipose Tissue in Stress Defense and Longevity","volume":"16","author":"Mori","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0835","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI73468","article-title":"Altered miRNA processing disrupts brown\/white adipocyte determination and associates with lipodystrophy","volume":"124","author":"Mori","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0840","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/jc.2015-3993","article-title":"Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients","volume":"101","author":"Torriani","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0845","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/jcb.22625","article-title":"An essential role for Dicer in adipocyte differentiation","volume":"110","author":"Mudhasani","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0850","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor \u03b3 (hPPAR\u03b3) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPAR\u03b32 Missense Mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0855","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0860","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPAR\u03b3 Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0865","first-page":"1076","article-title":"Heterogeneous Effect of Peroxisome Proliferator-activated Receptor \u03b32 Ala12 Variant on Type 2 Diabetes Risk","volume":"15","author":"Ornella","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0870","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPAR\u03b32 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0875","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cmet.2008.11.007","article-title":"The Pro12Ala PPAR\u03b32 Variant Determines Metabolism at the Gene-Environment Interface","volume":"9","author":"Heikkinen","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0880","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jmg.40.10.773","article-title":"Effect of the peroxisome proliferator activated receptor-\u03b3 gene Pro12Ala variant on body mass index: a meta-analysis","volume":"40","author":"Masud","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0885","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2156-3-21","article-title":"Haplotype analysis of the PPAR\u03b3 Pro12Ala and C1431T variants reveals opposing associations with body weight","volume":"3","author":"Doney","year":"2002","journal-title":"BMC Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0890","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2015.06.025","article-title":"Genetic Variation Determines PPAR\u03b3 Function and Anti-diabetic Drug Response in Vivo","volume":"162","author":"Soccio","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0895","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.2337\/diabetes.53.12.3274","article-title":"Genetic Determinants of Energy Expenditure and Insulin Resistance in Diet-Induced Obesity in Mice","volume":"53","author":"Almind","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0900","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.celrep.2018.07.063","article-title":"Peroxisome Proliferator-Activated Receptor &#x3b3;2 Controls the Rate of Adipose Tissue Lipid Storage and Determines Metabolic Flexibility","volume":"24","author":"Virtue","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0905","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00125-002-0873-y","article-title":"Adipose tissue as a buffer for daily lipid flux","volume":"45","author":"Frayn","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0910","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1210\/jc.2004-1494","article-title":"Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy","volume":"90","author":"Savage","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0915","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/diabetes.53.11.2748","article-title":"Regulation of Peroxisome Proliferator\u2013Activated Receptor-\u03b3 Activity by Mammalian Target of Rapamycin and Amino Acids in Adipogenesis","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0920","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.molmet.2016.04.001","article-title":"Raptor\/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0925","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/diabetes.50.3.686","article-title":"Evidence for Gene-Nutrient Interaction at the <em>PPAR<\/em>\u03b3 Locus","volume":"50","author":"Luan","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0930","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/ddg318","article-title":"Interaction between a peroxisome proliferator-activated receptor \u03b3 gene polymorphism and dietary fat intake in relation to body mass","volume":"12","author":"Memisoglu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0935","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1399-0004.2003.00026.x","article-title":"The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Qu\u00e9bec Family Study","volume":"63","author":"Robitaille","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0940","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/diabetes.50.3.686","article-title":"Evidence for Gene-Nutrient Interaction at the PPAR\u03b3 Locus","volume":"50","author":"Luan","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0945","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1172\/JCI200420964","article-title":"Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPAR\u03b3","volume":"114","author":"Tsai","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0950","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/db06-0389","article-title":"Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor \u03b3 function (P465L PPAR\u03b3) in mice","volume":"55","author":"Gray","year":"2006","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0955","doi-asserted-by":"crossref","first-page":"31771","DOI":"10.1074\/jbc.271.50.31771","article-title":"Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor \u03b3","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0960","series-title":"Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR\u03b3","author":"Hu","year":"1997"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0965","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cell.2011.09.050","article-title":"Adipocyte NCoR Knockout Decreases PPAR\u03b3 Phosphorylation and Enhances PPAR\u03b3 Activity and Insulin Sensitivity","volume":"147","author":"Li","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0970","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nature08262","article-title":"Initiation of myoblast to brown fat switch by a PRDM16-C\/EBP-beta transcriptional complex","volume":"460","author":"Kajimura","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2019.02.002_bb0975","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast Growth Factor-21 Regulates PPAR\u03b3 Activity and the Antidiabetic Actions of Thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0980","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molmet.2013.05.005","article-title":"Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones","volume":"2","author":"Adams","year":"2013","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0985","doi-asserted-by":"crossref","first-page":"16365","DOI":"10.1073\/pnas.1411086111","article-title":"c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2","volume":"111","author":"Keshet","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0990","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM199810013391403","article-title":"Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation","volume":"339","author":"Ristow","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb0995","first-page":"51","author":"Hegele","year":"2002","journal-title":"Brief Genetics Report"},{"issue":"Suppl 1","key":"10.1016\/j.bbalip.2019.02.002_bb1000","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","article-title":"Gender differences in insulin resistance, body composition, and energy balance","volume":"6","author":"Geer","year":"2009","journal-title":"Gend. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tem.2010.10.002","article-title":"Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity","volume":"22","author":"Mauvais-Jarvis","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1010","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/153537020422901107","article-title":"Role of Estrogens in Adipocyte Development and Function","volume":"229","author":"Cooke","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","article-title":"The sexual dimorphism of obesity","volume":"402","author":"Palmer","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbadis.2013.05.006","article-title":"Sex dimorphism and depot differences in adipose tissue function","volume":"1842","author":"White","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000010134","article-title":"Evaluation of the Body Composition and Fat Distribution in Long-Term Users of Hormone Replacement Therapy","volume":"48","author":"Perrone","year":"1999","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1030","first-page":"424","article-title":"Fat Distribution and Insulin Sensitivity in Postmenopausal Women: Influence of Hormone Replacement","volume":"10","author":"Julian","year":"2012","journal-title":"Obes. Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1365-2362.1996.145278.x","article-title":"Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue","volume":"26","author":"Pedersen","year":"1996","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1040","first-page":"1051","article-title":"Identification of steroid receptors in human adipose tissue","volume":"26","author":"P.S. B.","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1045","first-page":"950","article-title":"Identification of estrogen receptor in human adipose tissue and adipocytes","volume":"78","author":"Mizutani","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/bbrc.1998.8997","article-title":"Identification of Estrogen Receptor \u03b2 RNA in Human Breast and Abdominal Subcutaneous Adipose Tissue","volume":"248","author":"Crandall","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(01)00414-2","article-title":"The role of estrogen and estrogen receptor-\u03b1 in male adipose tissue","volume":"178","author":"Cooke","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1060","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-\u03b1 knockout mice","volume":"97","author":"Heine","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1065","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-2002-38259","article-title":"Effect of Ovariectomy on Adipose Tissue of Mice in the Absence of Estrogen Receptor Alpha (ER\u03b1): a Potential Role for Estrogen Receptor Beta (ER\u03b2)","volume":"34","author":"Naaz","year":"2002","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1070","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man","volume":"331","author":"Smith","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJMoa1303611","article-title":"Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor \u03b1 Variant","volume":"369","author":"Quaynor","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1080","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1006\/bbrc.2000.3827","article-title":"Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-\u03b1-Deficient Male Mice","volume":"278","author":"Ohlsson","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000108","article-title":"Metabolic Actions of Estrogen Receptor Beta (ER\u03b2) are Mediated by a Negative Cross-Talk with PPAR\u03b3","volume":"4","author":"Foryst-Ludwig","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1090","first-page":"1221","article-title":"Inhibition of Proliferation and Estrogen Receptor Signaling by Peroxisome Proliferator-activated Receptor \u03b3 Ligands in Uterine Leiomyoma","volume":"63","author":"Houston","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0303-7207(02)00154-5","article-title":"Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells","volume":"194","author":"Wang","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-007-9575-y","article-title":"Transactivation of ER\u03b1 by Rosiglitazone induces proliferation in breast cancer cells","volume":"108","author":"Talbert","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1105","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1074\/jbc.M209483200","article-title":"Peroxisome Proliferator-activated Receptor \u03b3 (PPAR\u03b3) as a Molecular Target for the Soy Phytoestrogen Genistein","volume":"278","author":"Dang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1110","first-page":"794","article-title":"Signaling cross-talk between peroxisome proliferator-activated receptor\/retinoid X receptor and estrogen receptor through estrogen response elements","volume":"9","author":"Keller","year":"1995","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0303-7207(96)03980-9","article-title":"Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor","volume":"127","author":"Nu\u00f1ez","year":"1997","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1120","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/1078-0432.CCR-04-2453","article-title":"Estrogen Receptor \u03b1 Binds to Peroxisome Proliferator\u2013Activated Receptor Response Element and Negatively Interferes with Peroxisome Proliferator\u2013Activated Receptor \u03b3 Signaling in Breast Cancer Cells","volume":"11","author":"Bonofiglio","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000315065","article-title":"The Role of Peroxisome Proliferator-Activated Receptor-\u03b3 and Estrogen Receptors in Genistein-Induced Regulation of Vascular Tone in Female Rat Aortas","volume":"86","author":"Xiang","year":"2010","journal-title":"Pharmacology."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1130","doi-asserted-by":"crossref","DOI":"10.1210\/en.2018-00149","article-title":"Profiling Of 3696 Nuclear Receptor-Coregulator Interactions: A Resource For Biological And Clinical Discovery","author":"Broekema","year":"2018","journal-title":"Endocrinology."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1135","doi-asserted-by":"crossref","first-page":"30131","DOI":"10.1074\/jbc.273.46.30131","article-title":"Estrogen-induced Production of a Peroxisome Proliferator-activated Receptor (PPAR) Ligand in a PPAR\u03b3-expressing Tissue","volume":"273","author":"Ma","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1140","first-page":"958","article-title":"Peroxisome Proliferator-activated Receptor \u03b3 Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor \u03b1 in MCF-7 Breast Cancer Cells","volume":"63","author":"Qin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1474-9726.2009.00490.x","article-title":"Aging alters PPAR\u03b3 in rodent and human adipose tissue by modulating the balance in steroid receptor coactivator\u20101","volume":"8","author":"St\u00e9phanie","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbalip.2019.02.002_bb1150","article-title":"Ablation of PPAR\u03b3 in subcutaneous fat exacerbates age\u2010associated obesity and metabolic decline","volume":"17","author":"Lingyan","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbalip.2019.02.002_bb1155","doi-asserted-by":"crossref","first-page":"561 LP","DOI":"10.1073\/pnas.1717776115","article-title":"Noncanonical agonist PPAR\u03b3 ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy","volume":"115","author":"Khandekar","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092622","article-title":"p53 Functions in Adipose Tissue Metabolism and Homeostasis","volume":"19","author":"Krstic","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1165","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2337\/db18-0684","article-title":"The Dysfunctional MDM2-p53 Axis in Adipocytes Contributes to Ageing Related Metabolic Complications by Induction of Lipodystrophy","volume":"67","author":"Liu","year":"2018","journal-title":"Diabetes."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1170","first-page":"1776","article-title":"Gender Differences in the Prevalence of Metabolic Complications in Familial Partial Lipodystrophy (Dunnigan Variety)*","volume":"85","author":"Garg","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2019.02.002_bb1175","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1210\/jc.2003-030485","article-title":"Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: Phenotype variability suggests important modifier effects","volume":"89","author":"Fu","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198118303019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198118303019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:03:01Z","timestamp":1761386581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198118303019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":235,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1388198118303019"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2019.02.002","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-gene and gene-environment interactions in lipodystrophy: Lessons learned from natural PPAR\u03b3 mutants","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}